Practice Management

The oncologist from the Morrison Cancer Center explained why he believes the general population should not receive multi-gene panel testing.

The organization indicated that patient safety should continue to be the first priority, and home infusion of anticancer therapy still presents with possible risks that should be considered.

Researchers specifically suggested that the 86-SNV score could be incorporated into breast cancer risk prediction models for patients carrying a pathogenic variant in BRCA1, BRCA2, and CHEK2.